$Flexion Therapeutics(FLXN)$ 内部交易: 2021-01-05,General Counsel,Levine Mark S. ,卖出,6829普通股, $11.13
$Flexion Therapeutics(FLXN)$ 内部交易: 2021-01-05,Chief Strategy Officer,Willwerth Christina ,卖出,6602普通股, $11.13
$Flexion Therapeutics(FLXN)$ 内部交易: 2021-01-05,Chief Regulatory Officer,Wentworth Kerry ,卖出,6829普通股, $11.13
$Flexion Therapeutics(FLXN)$ 内部交易: 2021-01-05,Chief Medical Officer,KELLEY SCOTT ,卖出,6829普通股, $11.13
$Flexion Therapeutics(FLXN)$ 内部交易: 2021-01-05,Chief Business Officer,Muzikant Adam ,卖出,4005普通股, $11.13
$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-002570 Size: 5 KB 网页链接
$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-002562 Size: 5 KB 网页链接
$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-002565 Size: 6 KB 网页链接
$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-002566 Size: 5 KB 网页链接
$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-002558 Size: 5 KB 网页链接